Free Trial

Semler Scientific (SMLR) Competitors

Semler Scientific logo
$61.78 +0.44 (+0.72%)
(As of 12/20/2024 05:51 PM ET)

SMLR vs. CNMD, TNDM, TMDX, SLNO, RXST, INMD, MDXG, ESTA, BLFS, and PLSE

Should you be buying Semler Scientific stock or one of its competitors? The main competitors of Semler Scientific include CONMED (CNMD), Tandem Diabetes Care (TNDM), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), RxSight (RXST), InMode (INMD), MiMedx Group (MDXG), Establishment Labs (ESTA), BioLife Solutions (BLFS), and Pulse Biosciences (PLSE). These companies are all part of the "medical equipment" industry.

Semler Scientific vs.

CONMED (NYSE:CNMD) and Semler Scientific (NASDAQ:SMLR) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, analyst recommendations, valuation, media sentiment, profitability, institutional ownership, risk, dividends and earnings.

CONMED has a beta of 1.46, meaning that its stock price is 46% more volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500.

49.4% of Semler Scientific shares are owned by institutional investors. 6.8% of CONMED shares are owned by company insiders. Comparatively, 30.2% of Semler Scientific shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Semler Scientific has a net margin of 27.00% compared to CONMED's net margin of 10.23%. Semler Scientific's return on equity of 20.31% beat CONMED's return on equity.

Company Net Margins Return on Equity Return on Assets
CONMED10.23% 13.84% 5.26%
Semler Scientific 27.00%20.31%18.78%

CONMED presently has a consensus target price of $79.80, indicating a potential upside of 16.28%. Given CONMED's higher probable upside, equities analysts plainly believe CONMED is more favorable than Semler Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CONMED
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
Semler Scientific
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00

CONMED has higher revenue and earnings than Semler Scientific. CONMED is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CONMED$1.29B1.65$64.46M$4.2116.30
Semler Scientific$58.94M8.69$20.58M$2.0530.14

CONMED received 33 more outperform votes than Semler Scientific when rated by MarketBeat users. However, 50.00% of users gave Semler Scientific an outperform vote while only 47.22% of users gave CONMED an outperform vote.

CompanyUnderperformOutperform
CONMEDOutperform Votes
34
47.22%
Underperform Votes
38
52.78%
Semler ScientificOutperform Votes
1
50.00%
Underperform Votes
1
50.00%

In the previous week, Semler Scientific had 6 more articles in the media than CONMED. MarketBeat recorded 7 mentions for Semler Scientific and 1 mentions for CONMED. CONMED's average media sentiment score of 1.63 beat Semler Scientific's score of 0.51 indicating that CONMED is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CONMED
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Semler Scientific
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Semler Scientific beats CONMED on 11 of the 19 factors compared between the two stocks.

Get Semler Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMLR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SMLR vs. The Competition

MetricSemler ScientificElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$512.09M$3.01B$5.06B$9.08B
Dividend YieldN/A1.75%4.84%4.21%
P/E Ratio30.1416.15102.6717.15
Price / Sales8.6950.121,121.74116.80
Price / Cash21.8039.9141.3037.88
Price / Book5.913.724.744.78
Net Income$20.58M$89.83M$119.11M$225.60M
7 Day Performance-8.02%-1.82%-1.86%-1.21%
1 Month Performance-5.87%0.28%11.37%3.09%
1 Year Performance40.54%4.10%30.22%16.48%

Semler Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMLR
Semler Scientific
1.3135 of 5 stars
$61.78
+0.7%
N/A+44.1%$572.54M$58.94M30.1492Gap Up
CNMD
CONMED
4.6156 of 5 stars
$71.57
-1.4%
$79.80
+11.5%
-36.7%$2.21B$1.29B17.234,000Positive News
TNDM
Tandem Diabetes Care
4.6387 of 5 stars
$33.09
+1.3%
$53.81
+62.6%
+30.3%$2.17B$747.72M-16.922,400Positive News
TMDX
TransMedics Group
4.0342 of 5 stars
$63.72
-0.8%
$126.80
+99.0%
-20.1%$2.14B$241.62M68.36210Analyst Forecast
SLNO
Soleno Therapeutics
4.4752 of 5 stars
$48.55
+3.9%
$74.83
+54.1%
+25.5%$2.09BN/A-14.0730Positive News
RXST
RxSight
2.9587 of 5 stars
$38.79
+4.0%
$62.13
+60.2%
-11.8%$1.56B$89.08M-46.59220Analyst Downgrade
Gap Down
INMD
InMode
3.6286 of 5 stars
$18.12
-0.8%
$22.60
+24.7%
-21.7%$1.52B$423.75M9.87480Positive News
MDXG
MiMedx Group
2.8171 of 5 stars
$9.50
+3.7%
$12.00
+26.3%
+1.7%$1.40B$342.80M16.65895
ESTA
Establishment Labs
2.5284 of 5 stars
$46.74
+1.6%
$60.60
+29.7%
+73.3%$1.31B$153.07M-17.83960Positive News
BLFS
BioLife Solutions
1.2686 of 5 stars
$27.28
+2.2%
$28.29
+3.7%
+79.4%$1.27B$146.96M-25.19409Analyst Forecast
Insider Trade
News Coverage
Gap Down
PLSE
Pulse Biosciences
1.8696 of 5 stars
$20.21
+14.5%
N/A+56.3%$1.24B$700,000.000.00140Insider Trade
News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:SMLR) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners